Data / Research funding / Stem Cell Research - Induced Pluripotent Stem Cell
Stem Cell Research - Induced Pluripotent Stem Cell: 1,451 NIH awards ($1.4B) to 303 organizations
1,451 NIH awards ($1.4B) in the NIH spending category Stem Cell Research - Induced Pluripotent Stem Cell, to 303 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
Get awards on Stem Cell Research - Induced Pluripotent Stem CellWatch Stem Cell Research - Induced Pluripotent Stem Cell
- Topic
- NIH spending category
Awards
The 500 largest of 1,451 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2024 | $39,202,732 | July 1, 2003 | February 28, 2026 | KNOWLES, JAMES A | reporter.nih.gov |
| UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $21,851,455 | September 1, 2025 | August 31, 2026 | SCHULICK, RICHARD D | reporter.nih.gov |
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| CWRU Center for Excellence on the Impact of Substance Use on HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,213,687 | September 15, 2021 | May 31, 2027 | LEVINE, ALAN DAVID | reporter.nih.gov |
| The Alzheimer's Disease Research Center at the University of California, Irvine | NIH | National Institute on Aging | 2021 to 2025 | $16,032,156 | June 15, 2020 | March 31, 2030 | LAFERLA, FRANK M | reporter.nih.gov |
| Therapeutic gene editing and multimodal imaging in juvenile macular degeneration | NIH | National Eye Institute | 2021 to 2024 | $8,710,741 | June 1, 2020 | May 31, 2026 | TSANG, STEPHEN H | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,998,766 | August 20, 2020 | June 30, 2025 | SEALE, PATRICK | reporter.nih.gov |
| FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $6,546,370 | September 25, 2020 | June 30, 2025 | JIN, PENG | reporter.nih.gov |
| From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $6,459,020 | May 15, 2019 | April 30, 2025 | BERNSTEIN, DANIEL | reporter.nih.gov |
| Molecular Circuits in the Hematopoietic Stem Cell Niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,422,507 | August 15, 2020 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Metals and Metal Mixtures: Cognitive Aging, Remediation and Exposure Sources (MEMCARE) | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $6,396,550 | February 21, 2020 | May 9, 2025 | LU, QUAN | reporter.nih.gov |
| Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $6,353,055 | May 15, 2020 | April 30, 2026 | TSAI, LI-HUEI | reporter.nih.gov |
| Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $5,901,662 | August 15, 2020 | May 31, 2026 | POLLAK, MARTIN R. | reporter.nih.gov |
| A Human iPSC-based Cell Therapy for Canavan Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,276,950 | June 15, 2021 | May 31, 2027 | SHI, YANHONG | reporter.nih.gov |
| Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,582,323 | September 20, 2018 | July 31, 2024 | STAHL, ANDREAS | reporter.nih.gov |
| Illuminating Function of the Understudied Druggable Kinome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,503,990 | September 15, 2017 | December 31, 2024 | JOHNSON, GARY L. | reporter.nih.gov |
| UAB Childhood Cystic Kidney Disease Center (UAB-CCKDC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,330,298 | July 20, 2020 | August 31, 2030 | YODER, BRADLEY K. | reporter.nih.gov |
| Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,324,679 | September 20, 2018 | July 31, 2023 | TAYLOR, D. LANSING | reporter.nih.gov |
| Development and Expansion of the Human Cerebral Cortex | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,211,732 | December 1, 2016 | November 30, 2024 | KRIEGSTEIN, ARNOLD | reporter.nih.gov |
| Genetic neuroscience: How human genes and alleles shape neuronal phenotypes | NIH | National Institute of Mental Health | 2021 | $4,026,586 | September 20, 2017 | July 31, 2023 | MCCARROLL, STEVEN ANDREW | reporter.nih.gov |
| BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD)- TASK A. CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,969,819 | September 1, 2020 | August 31, 2025 | WU, JOSEPH | reporter.nih.gov |
| Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,926,545 | March 1, 2018 | February 28, 2026 | NEWMAN, PETER J | reporter.nih.gov |
| Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue | NIH | National Institute on Aging | 2021 to 2024 | $3,903,556 | May 1, 2020 | April 30, 2026 | TESCO, GIUSEPPINA | reporter.nih.gov |
| Perturbing the LXR/SREBP axis to decipher protective and pathogenic AD/ADRD microglial phenotypes | NIH | National Institute on Aging | 2024 | $3,840,870 | May 1, 2024 | April 30, 2027 | GLASS, CHRISTOPHER K | reporter.nih.gov |
| A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy | NIH | National Eye Institute | 2021 to 2024 | $3,781,701 | September 30, 2021 | July 31, 2026 | FU, YINGBIN | reporter.nih.gov |
| Elucidating the Biological Differences Between Distinct Fibrillar and Non-Fibrillar Alpha-Synuclein Inclusions in Human Stem-Cell Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,706,946 | July 1, 2020 | April 30, 2026 | KHURANA, VIKRAM | reporter.nih.gov |
| Cellular consequences and convergent biology of schizophrenia-associated rare variants in the diverse GPC cohort | NIH | National Institute of Mental Health | 2022 to 2024 | $3,678,769 | August 1, 2022 | May 31, 2027 | MULLE, JENNIFER GLADYS | reporter.nih.gov |
| Construction of an Integrated Immune - Vascular Brain - Chip as a Platform for the Study, Drug Screening, and Treatments of Alzheimer's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $3,475,569 | September 20, 2019 | May 31, 2024 | TSAI, LI-HUEI | reporter.nih.gov |
| Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,437,163 | December 1, 2016 | November 30, 2024 | MING, GUO-LI | reporter.nih.gov |
| Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $3,386,194 | September 15, 2020 | May 31, 2026 | ZHANG, BIN | reporter.nih.gov |
| Microphysiological systems for modeling autoimmunity in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,372,768 | August 2, 2019 | July 31, 2025 | STANGER, BEN Z | reporter.nih.gov |
| Genetic Control of Cardiac Development: Congenital Heart Disease Gene Discovery in Drosophila | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,338,929 | August 1, 1995 | June 30, 2025 | BODMER, ROLF | reporter.nih.gov |
| Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,303,112 | September 15, 2020 | June 30, 2025 | SUH, YOUSIN | reporter.nih.gov |
| Cell specific delivery of novel therapies to enhance glomerular regeneration and repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,199,320 | September 1, 2020 | May 31, 2025 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV | NIH | National Institute on Aging | 2021 to 2024 | $3,183,836 | May 1, 2020 | February 28, 2026 | MA, QING | reporter.nih.gov |
| Ex Vivo Generation of Functional Kidney Tissues for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,161,308 | September 1, 2020 | May 14, 2025 | LEWIS, JENNIFER A. | reporter.nih.gov |
| Modeling diabetes using an integrated plate system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,092,998 | September 20, 2018 | July 31, 2024 | WELLS, JAMES M | reporter.nih.gov |
| Genetic determinants of 4D genome folding in human cardiac development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,069,960 | September 21, 2020 | August 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $3,026,491 | September 30, 2018 | August 31, 2024 | REX, TONIA S | reporter.nih.gov |
| Investigating the role of adipose tissue in mobility and aging (SOMMA-AT) | NIH | National Institute on Aging | 2021 to 2024 | $3,021,652 | September 15, 2020 | May 31, 2025 | SPARKS, LAUREN MARIE | reporter.nih.gov |
| Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models | NIH | National Institute on Aging | 2021 to 2024 | $3,018,880 | August 15, 2020 | April 30, 2026 | WEN, ZHEXING | reporter.nih.gov |
| A 3D vascularized islet biomimetic to model type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,017,660 | August 1, 2019 | January 31, 2025 | SANDER, MAIKE | reporter.nih.gov |
| Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $3,003,024 | August 1, 2018 | July 31, 2024 | WIKSWO, JOHN PETER | reporter.nih.gov |
| BRITE-Eye: An integrated discovery engine for CNS therapeutic targets driven by high throughput genetic screens, functional readouts in human neurons, and machine learning | NIH | National Institute of Mental Health | 2023 to 2024 | $2,999,997 | September 19, 2023 | August 31, 2025 | WILLIAMS, LUIS ALBERTO | reporter.nih.gov |
| Impact of peripheral nerves on mesenchymal cell fate in extremity trauma | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,991,689 | August 1, 2017 | April 30, 2026 | LEVI, BENJAMIN | reporter.nih.gov |
| Defining Genetic Architecture and Pathways of DCM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,976,096 | April 1, 2005 | January 31, 2026 | SEIDMAN, JONATHAN G | reporter.nih.gov |
| TREM2-mediated microglial dynamic function in Alzheimer disease | NIH | National Institute on Aging | 2021 to 2024 | $2,968,448 | February 1, 2020 | December 31, 2025 | ZHAO, NA | reporter.nih.gov |
| Defining disease mechanisms in SLC35A2 epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,951,492 | July 1, 2020 | April 30, 2025 | HEINZEN, ERIN L | reporter.nih.gov |
| Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,950,878 | December 1, 2016 | November 30, 2024 | GUTMANN, DAVID H | reporter.nih.gov |
| Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome | NIH | National Institute on Aging | 2021 to 2024 | $2,943,744 | April 15, 2020 | March 31, 2026 | FINKBEINER, STEVEN M | reporter.nih.gov |
| Polyunsaturated fatty acids as anti-arrhythmic agents. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,942,029 | September 15, 2016 | March 31, 2026 | BARRO-SORIA, RENE | reporter.nih.gov |
| Mechanistic Basis of Cardiac Laminopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,934,243 | September 16, 2021 | June 30, 2026 | WORMAN, HOWARD J | reporter.nih.gov |
| Identifying Alzheimer’s Disease Causal Variants and Target Genes Using iPSC-derived Microglia | NIH | National Institute on Aging | 2021 to 2024 | $2,922,756 | April 15, 2020 | March 31, 2025 | PHANSTIEL, DOUGLAS H. | reporter.nih.gov |
| Induced neuronal cells: A novel tool to study neuropsychiatric diseases | NIH | National Institute of Mental Health | 2021 to 2024 | $2,918,957 | September 29, 2010 | August 31, 2025 | WERNIG, MARIUS | reporter.nih.gov |
| Dissecting the role of NOTCH2NL genes in human brain development and neurological disorders associated with chromosome 1q21.1 distal duplications and deletions. | NIH | National Institute of Mental Health | 2021 to 2024 | $2,907,904 | April 15, 2020 | January 31, 2026 | SALAMA, SOFIE REDA | reporter.nih.gov |
| Retinal disease models for translational photoreceptor replacement | NIH | National Eye Institute | 2021 to 2022 | $2,898,123 | September 30, 2018 | May 31, 2025 | WOLFE, JOHN H | reporter.nih.gov |
| Study the Protective Roles of ApoE2 in Alzheimer's Disease Using Reprogrammed Isogenic Cells | NIH | National Institute on Aging | 2021 to 2024 | $2,897,144 | May 1, 2020 | March 31, 2025 | HUANG, YADONG | reporter.nih.gov |
| Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease | NIH | National Institute of Mental Health | 2023 to 2024 | $2,885,988 | September 15, 2023 | August 31, 2025 | SACHS, KAREN | reporter.nih.gov |
| The Pathogenesis of RNA Splicing Factor Associated Retinal Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,874,308 | April 1, 2011 | March 31, 2026 | PIERCE, ERIC A | reporter.nih.gov |
| Translational assessment of brain bioenergetic function in schizophrenia | NIH | National Institute of Mental Health | 2021 to 2024 | $2,863,277 | December 1, 2019 | October 31, 2025 | MARANO, CHRISTOPHER | reporter.nih.gov |
| Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,861,646 | January 1, 2017 | December 31, 2024 | GINSBERG, HENRY N | reporter.nih.gov |
| Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,859,989 | September 1, 2022 | August 31, 2025 | CHENG, CHRISTINE | reporter.nih.gov |
| Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,844,000 | August 15, 2021 | June 30, 2025 | BOROK, ZEA | reporter.nih.gov |
| Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research | NIH | National Eye Institute | 2021 to 2022 | $2,820,106 | September 30, 2018 | August 31, 2022 | CARROLL, JOSEPH | reporter.nih.gov |
| Genotype-guided therapy for atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,771,945 | July 15, 2020 | June 30, 2026 | DARBAR, DAWOOD | reporter.nih.gov |
| Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,764,144 | June 1, 2021 | July 31, 2025 | PRICE, JEFFREY H. | reporter.nih.gov |
| Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patients’ induced pluripotent stem cells and genome editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,760,413 | May 1, 2020 | April 30, 2026 | YANG, BO | reporter.nih.gov |
| Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,741,939 | September 5, 2023 | August 31, 2025 | AHMED, SYED MUKHTAR | reporter.nih.gov |
| Sex-specific Molecular Profiling to Understand Pathology and Identify Causal Genes and Drug Targets for Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $2,740,705 | September 30, 2021 | August 31, 2024 | SUNG, YUNJU | reporter.nih.gov |
| Synergistic Mechanisms of chronic Innate Immune Activation in Microglia by Opiates and HIV Infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,732,942 | July 15, 2020 | April 30, 2026 | GUMMULURU, SURYARAM | reporter.nih.gov |
| Charting the 3D epigenome in human brain development and diseases | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,724,871 | September 30, 2020 | August 31, 2025 | SHEN, YIN | reporter.nih.gov |
| 1/7 Collaborative Genomic Studies of Tourette Disorder. | NIH | National Institute of Mental Health | 2021 to 2023 | $2,683,588 | June 15, 2018 | March 31, 2025 | HEIMAN, GARY A. | reporter.nih.gov |
| Defining Characteristics of Cortical Progenitor Cells over Time in Mouse and Human | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,620,540 | December 15, 2016 | November 30, 2025 | TEMPLE, SALLY | reporter.nih.gov |
| Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models | NIH | National Institute on Aging | 2022 | $2,618,631 | August 15, 2022 | July 31, 2025 | CLINE, HOLLIS T. | reporter.nih.gov |
| Synthetic gene sensors and effectors to redirect organoid development | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,608,452 | May 1, 2021 | July 31, 2025 | WEISS, RON | reporter.nih.gov |
| Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 | $2,601,749 | September 1, 2021 | August 31, 2024 | KELLY, JEFFERY W | reporter.nih.gov |
| NATIONAL BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS:THE PURPOSE OF THIS RESOURCE IS TO BUILD AND SUPPORT A CRITICAL | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,600,000 | May 1, 2020 | April 30, 2025 | N/A, N/A | reporter.nih.gov |
| Probing the Cardiac PGC-1 Regulatory Cascade | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,593,540 | April 1, 1998 | March 31, 2025 | KELLY, DANIEL PATRICK | reporter.nih.gov |
| Pediatric Heart Disease: Getting from Mutations to Therapeutics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,582,324 | February 15, 2017 | January 31, 2025 | GELB, BRUCE D | reporter.nih.gov |
| Identifying cell type-specific autonomous and non-autonomous interactions in AD | NIH | National Institute on Aging | 2022 | $2,567,371 | May 1, 2022 | April 30, 2025 | MENON, VILAS | reporter.nih.gov |
| Neuronal excitability and copy number variation disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,563,265 | September 1, 2020 | May 31, 2026 | PENZES, PETER | reporter.nih.gov |
| Cellular models of fetal neurodevelopment in maternal SARS-CoV-2 infection | NIH | National Institute of Mental Health | 2022 | $2,560,905 | September 15, 2022 | September 14, 2025 | EDLOW, ANDREA GOLDBERG | reporter.nih.gov |
| Biomarker discovery for parkinsonian diseases in extracellular vesicles from iPSC-derived neurons | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $2,555,369 | April 1, 2023 | March 31, 2026 | BITAN, GAL | reporter.nih.gov |
| Three-dimensional conformation changes associated with T cell memory and autoimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,550,277 | September 15, 2020 | June 30, 2025 | HAWKINS, RAYMOND DAVID | reporter.nih.gov |
| A Human iPSC-Based Chimeric Mouse Model of Alzheimers Disease in Down Syndrome | NIH | National Institute on Aging | 2021 to 2024 | $2,549,299 | September 30, 2021 | August 31, 2026 | JIANG, PENG | reporter.nih.gov |
| Functional roles of lymphatics in organogenesis and tissue repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,543,362 | January 7, 2021 | December 31, 2025 | OLIVER, GUILLERMO C | reporter.nih.gov |
| 1/2 Cell Type and Region-Specific Regulatory Networks in Human Brain Development and Disorders | NIH | National Institute of Mental Health | 2021 to 2022 | $2,541,620 | July 6, 2018 | March 31, 2024 | SESTAN, NENAD | reporter.nih.gov |
| Cellular and Molecular Analysis of the Psychiatric Risk Gene Transcription Factor 4 (TCF4) | NIH | National Institute of Mental Health | 2021 to 2024 | $2,540,401 | September 2, 2016 | May 31, 2026 | MAHER, BRADY J | reporter.nih.gov |
| Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,537,267 | January 1, 2018 | November 30, 2025 | GAO, FEN-BIAO | reporter.nih.gov |
| Gaining insight into psychiatric disease by engineering piece by piece the human brain in vitro. | NIH | National Institute of Mental Health | 2021 to 2024 | $2,536,379 | August 1, 2015 | May 31, 2025 | PASCA, SERGIU | reporter.nih.gov |
| Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,528,360 | September 15, 2016 | May 31, 2025 | CHOU, STELLA T | reporter.nih.gov |
| Prenatal Origins of Neurometabolic Consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,517,422 | September 1, 2021 | July 31, 2026 | DEVASKAR, SHERIN U | reporter.nih.gov |
| Molecular and Cellular Dissection of the Pathogenesis of Herpes Simplex Encephalitis with iPSC-Derived CNS and PNS Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,509,626 | September 20, 2010 | March 31, 2025 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Editing Alveolar Progenitor Cells for Correction of Monogenic Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,504,499 | September 23, 2016 | May 31, 2025 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,498,183 | September 30, 2020 | August 31, 2025 | PHILLIPS-CREMINS, JENNIFER ELIZABETH | reporter.nih.gov |
| Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,496,816 | September 18, 2020 | August 31, 2025 | LI, WENBO | reporter.nih.gov |
| Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4 Diversity Supplement | NIH | National Institute on Aging | 2022 to 2024 | $2,493,260 | May 15, 2022 | April 30, 2025 | YASSINE, HUSSEIN N | reporter.nih.gov |
| Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD | NIH | National Institute on Aging | 2022 | $2,481,834 | August 2, 2022 | July 31, 2025 | ALBERS, MARK W | reporter.nih.gov |
| Developing a patient-specific organoid model of pulmonary fibrosis using iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,476,283 | December 15, 2020 | November 30, 2025 | KOTTON, DARRELL N. | reporter.nih.gov |
| Personalizing Class I anti-Arrhythmic Drug Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,473,840 | April 1, 2020 | March 31, 2026 | SILVA, JONATHAN R | reporter.nih.gov |
| HIV, Methamphetamine and Human iPSC-derived Microglia-containing Cerebral Organoids | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,470,488 | July 1, 2020 | April 30, 2026 | HO, WENZHE | reporter.nih.gov |
| Regulation of endothelial cell specification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,466,084 | February 15, 2021 | January 31, 2025 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Identifying pathways required for integration of kidney organoid and host epithelia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,461,009 | September 1, 2020 | May 31, 2025 | DRUMMOND, IAIN A. | reporter.nih.gov |
| Role of central and peripheral immune crosstalk in FTD-Grn neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,446,942 | August 17, 2022 | July 30, 2025 | TANSEY, MARIA DE LOURDES GAMEZ | reporter.nih.gov |
| Higher Order Chromatin and Genetic Risk for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2023 | $2,446,779 | January 15, 2015 | July 31, 2025 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Humanized Mouse Avatars for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,439,759 | September 25, 2014 | May 31, 2024 | GREINER, DALE LESLIE | reporter.nih.gov |
| Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,438,130 | February 1, 2021 | January 31, 2024 | SIGURDSSON, EINAR M | reporter.nih.gov |
| Stem cells for therapeutics discovery in genetic blood disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,429,809 | September 23, 2016 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Function of Putative Determinant in Hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,418,427 | August 1, 1993 | June 30, 2026 | BIEKER, JAMES J | reporter.nih.gov |
| Novel tools for in vitro electrophysiology and neurotrauma modeling | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,414,021 | August 17, 2020 | January 31, 2026 | FINAN, JOHN D | reporter.nih.gov |
| Gene regulatory networks for heart development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,410,652 | January 1, 2021 | December 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery | NIH | National Institute on Aging | 2023 | $2,399,582 | September 1, 2023 | August 31, 2026 | MACHAIRAKI, VASILIKI | reporter.nih.gov |
| Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing | NIH | National Institute on Aging | 2023 | $2,394,473 | May 15, 2023 | April 30, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,388,592 | September 21, 2016 | May 31, 2025 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,385,538 | September 15, 2017 | February 28, 2024 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool. | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,380,820 | September 26, 2019 | July 31, 2025 | MAIDMENT, NIGEL T | reporter.nih.gov |
| Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,375,761 | May 1, 2020 | April 30, 2026 | ZHANG, HANRUI | reporter.nih.gov |
| Genome Wide Association Study for Childhood Obesity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,372,606 | July 15, 2008 | June 30, 2026 | GRANT, STRUAN F A | reporter.nih.gov |
| Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,367,083 | February 15, 2021 | January 31, 2026 | GOMPERTS, BRIGITTE N | reporter.nih.gov |
| C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches | NIH | National Institute on Aging | 2021 to 2022 | $2,365,559 | May 1, 2021 | April 30, 2024 | CONKLIN, BRUCE R | reporter.nih.gov |
| Synaptopathy and Pathogenesis in Frontotemporal Dementia: Role of CYLD | NIH | National Institute on Aging | 2023 | $2,364,013 | June 1, 2023 | May 31, 2026 | YAO, WEI-DONG | reporter.nih.gov |
| Regulation of HIV latency by microglial-neuronal interactions | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,363,459 | September 15, 2019 | July 31, 2025 | KARN, JONATHAN | reporter.nih.gov |
| Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease | NIH | National Institute on Aging | 2021 | $2,360,820 | March 1, 2021 | February 29, 2024 | RAJ, TOWFIQUE | reporter.nih.gov |
| Generation of four-chambered hearts through organoid fusions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,358,480 | September 1, 2024 | August 31, 2026 | LI, GUANG | reporter.nih.gov |
| Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screening | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $2,355,934 | February 15, 2018 | January 31, 2025 | LEONG, KAM W | reporter.nih.gov |
| Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,348,133 | September 1, 2019 | July 31, 2025 | RANA, TARIQ M | reporter.nih.gov |
| Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,344,291 | August 18, 2023 | July 31, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Targeting the genotype to phenotype link in HCM as a therapeutic strategy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,339,175 | March 1, 2021 | February 28, 2026 | MERCOLA, MARK | reporter.nih.gov |
| Developmental Origin, Injury and Epigenomic Regulation of NF1-Associated Peripheral Nerve Sheath Tumors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,339,120 | April 15, 2021 | June 30, 2024 | ZHU, YUAN | reporter.nih.gov |
| 2/7-Collaborative genomic studies of Tourette Disorder | NIH | National Institute of Mental Health | 2021 to 2022 | $2,333,736 | July 27, 2018 | September 30, 2023 | STATE, MATTHEW W. | reporter.nih.gov |
| Integrated Cellular and Tissue Engineering for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,333,316 | September 15, 2016 | May 31, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,332,346 | September 15, 2020 | December 31, 2022 | TSE, HUBERT M | reporter.nih.gov |
| Targeting Aging to prevent Alzheimer's Disease: the Geroscience Approach | NIH | National Institute on Aging | 2021 to 2024 | $2,327,496 | April 15, 2020 | September 30, 2025 | LITHGOW, GORDON J | reporter.nih.gov |
| Nextgen AD Models, Endotypes, and Screening | NIH | National Institute on Aging | 2024 | $2,319,456 | June 1, 2024 | May 31, 2027 | SUBRAMANIAM, SHANKAR | reporter.nih.gov |
| Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development | NIH | National Cancer Institute | 2021 to 2024 | $2,319,039 | September 1, 2020 | August 31, 2025 | SLINGERLAND, JOYCE MARIE | reporter.nih.gov |
| Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease | NIH | National Institute of Mental Health | 2021 to 2023 | $2,314,430 | July 18, 2019 | April 30, 2025 | FANG, GANG | reporter.nih.gov |
| Transplantation of MHC Homozygous Vascular Progenitors in Primates | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,302,970 | September 20, 2016 | May 31, 2025 | SLUKVIN, IGOR I. | reporter.nih.gov |
| Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management | NIH | National Center for Advancing Translational Sciences | 2021 | $2,287,391 | September 26, 2019 | July 31, 2025 | GOLD, MICHAEL S | reporter.nih.gov |
| ApoE, lipid and immune mechanisms of human neurons and glia | NIH | National Institute on Aging | 2023 | $2,284,296 | December 15, 2022 | November 30, 2025 | ISACSON, OLE | reporter.nih.gov |
| Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,281,119 | September 1, 2020 | June 30, 2025 | LARGAESPADA, DAVID ANDREW | reporter.nih.gov |
| Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,260,661 | September 15, 2020 | June 30, 2025 | CHEN, SHUIBING | reporter.nih.gov |
| Loss of TDP-43 disrupts the prefrontal neural activity and circuitry: relevance for TDP-43 linked ADRD | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,255,378 | September 19, 2022 | August 31, 2025 | LI, YUN | reporter.nih.gov |
| Functional Genomics of Tibetan Adaptations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,246,453 | April 1, 2014 | June 30, 2025 | DI RIENZO, ANNA | reporter.nih.gov |
| Functional Validation of TDP-43 splicing repression for frontotemporal degeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,237,856 | September 1, 2021 | August 31, 2023 | WONG, PHILIP C | reporter.nih.gov |
| PCTC Administrative Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,233,284 | September 20, 2016 | May 31, 2025 | TERRIN, MICHAEL L | reporter.nih.gov |
| Genetic Regulation of Nonalcoholic Fatty Liver Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,221,739 | June 8, 2021 | March 31, 2026 | MEDINA, MARISA WONG | reporter.nih.gov |
| Development of a Synthetic, Cell-Permeable Peptide for the Inhibition of CDK5-p25 Hyperactivity in Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,210,678 | September 22, 2021 | August 31, 2024 | WERNER, JOHN KENT | reporter.nih.gov |
| Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,208,551 | July 15, 2020 | May 2, 2024 | NIXON, DOUGLAS F | reporter.nih.gov |
| Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease | NIH | National Institute on Aging | 2021 | $2,207,391 | May 1, 2021 | April 30, 2024 | POON, WAYNE W | reporter.nih.gov |
| Mechanisms of epithelial repair and remodeling in pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,193,295 | July 15, 2020 | June 30, 2025 | KROPSKI, JONATHAN ANDREW | reporter.nih.gov |
| A Novel Role for NFATC1 in Modulating Cardiac Excitability | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,192,974 | July 1, 2020 | June 30, 2025 | TRISTANI-FIROUZI, MARTIN | reporter.nih.gov |
| Molecular Segregation of Parkinson’s Disease by Patient-Derived Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,183,720 | June 1, 2020 | May 31, 2026 | FENG, JIAN | reporter.nih.gov |
| Mechanisms of gene regulation and RNA processing in synucleinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,181,405 | July 1, 2020 | June 30, 2025 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Novel patient-derived 3D platform for detecting TDP-43 proteinopathy and associated biomarkers for ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $2,175,360 | February 15, 2022 | January 31, 2025 | GHAFFARI, LAYLA | reporter.nih.gov |
| Resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis | NIH | National Institute on Aging | 2024 | $2,173,794 | September 1, 2024 | August 31, 2027 | CHOI, SE HOON | reporter.nih.gov |
| A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,172,600 | August 15, 2020 | July 31, 2025 | AWAD, HANI A | reporter.nih.gov |
| Sox Proteins Modulate Genomic Specificity of B-catenin Regulated Transcription in the Developing Gut | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,163,911 | January 15, 2021 | December 31, 2025 | ZORN, AARON M | reporter.nih.gov |
| The µSiM-hNVU - a human BBB platform for the study of brain injury mechanisms during systemic infection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,162,325 | September 3, 2020 | August 31, 2025 | MCGRATH, JAMES L | reporter.nih.gov |
| Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,159,148 | September 20, 2022 | August 31, 2025 | KITAZAWA, MASASHI | reporter.nih.gov |
| Role of SCN1B in Inherited Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,149,827 | February 1, 2011 | January 31, 2025 | ISOM, LORI L. | reporter.nih.gov |
| Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical Care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,141,117 | July 1, 2020 | June 30, 2025 | QYANG, YIBING | reporter.nih.gov |
| Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $2,135,509 | August 1, 2020 | July 31, 2025 | KAPAHI, PANKAJ | reporter.nih.gov |
| Toward Understanding the Role of the Polycomb Complex in Skin Control | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,130,652 | February 1, 2016 | August 31, 2025 | EZHKOVA, ELENA | reporter.nih.gov |
| Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,124,884 | February 1, 2020 | October 31, 2025 | HARRISON, FIONA EDITH | reporter.nih.gov |
| Development of CRISPR/Cas9-based exon-skipping strategies for the treatment of USH-associated deafness | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2024 | $2,113,099 | August 22, 2022 | June 30, 2027 | LIU, XUE Z | reporter.nih.gov |
| Modeling Alzheimer's disease genetic variants in hiPSC | NIH | National Institute on Aging | 2021 to 2023 | $2,102,361 | May 1, 2019 | February 28, 2025 | DUAN, JUBAO | reporter.nih.gov |
| Genetic Regulation of Inner, Middle and Outer Ear Development | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,101,738 | March 22, 2013 | November 30, 2025 | GROVES, ANDREW K | reporter.nih.gov |
| Cardiac Mechanisms of Sudden Unexpected Death in Epilepsy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,101,543 | July 1, 2020 | June 30, 2025 | ISOM, LORI L. | reporter.nih.gov |
| Targeting Dyrk1a to Promote Donor-independent Platelet Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,097,567 | February 20, 2020 | January 31, 2025 | GOLDFARB, ADAM N. | reporter.nih.gov |
| Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,096,374 | August 1, 2014 | May 31, 2025 | SOTO-GUTIERREZ, ALEJANDRO | reporter.nih.gov |
| Mechanisms and Regulation of Brain Iron Uptake | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,095,116 | December 1, 2019 | November 30, 2025 | CONNOR, JAMES ROBERT | reporter.nih.gov |
| Cell Type and Regional Vulnerability in Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,094,351 | August 1, 2021 | July 31, 2024 | TEMPLE, SALLY | reporter.nih.gov |
| Understanding Frontotemporal Dementia Using Drosophila and iPSC Models | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,086,468 | April 15, 2017 | March 31, 2025 | GAO, FEN-BIAO | reporter.nih.gov |
| Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,085,642 | August 1, 2019 | June 30, 2025 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,085,362 | January 5, 2023 | December 31, 2025 | WAINGER, BRIAN JASON | reporter.nih.gov |
| Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infection | NIH | National Eye Institute | 2021 to 2024 | $2,079,783 | January 1, 2021 | December 31, 2025 | ARUMUGASWAMI, VAITHILINGARAJA | reporter.nih.gov |
| Connecting 3D genome misfolding to transcriptional silencing in fragile X syndrome | NIH | National Institute of Mental Health | 2021 to 2024 | $2,066,257 | August 15, 2019 | January 31, 2029 | PHILLIPS-CREMINS, JENNIFER ELIZABETH | reporter.nih.gov |
| Neuronal ABCA7 loss of function and Alzheimer’s disease | NIH | National Institute on Aging | 2023 | $2,063,098 | June 1, 2023 | May 31, 2026 | KANEKIYO, TAKAHISA | reporter.nih.gov |
| The Role of PRDM16 in Cardiac Development and Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,054,619 | July 15, 2020 | May 31, 2025 | BOUDINA, SIHEM | reporter.nih.gov |
| Bone marrow-targeted extracellular vesicles as a novel non-viral gene editor delivery platform | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $2,051,588 | July 1, 2022 | May 31, 2025 | THON, JONATHAN N | reporter.nih.gov |
| Cancer patient on a chip | NIH | National Cancer Institute | 2021 to 2024 | $2,041,238 | July 15, 2020 | June 30, 2025 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Neuronal quality control and neuroprotection in tauopathies | NIH | National Institute on Aging | 2021 to 2024 | $2,040,301 | August 1, 2007 | April 30, 2026 | CHU, CHARLEEN T | reporter.nih.gov |
| Aortic Valve Disease: Mechanisms and Therapeutic Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,037,372 | February 10, 2020 | January 31, 2025 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Structure function relationships from deep mutational scanning in human cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,035,543 | January 1, 2020 | December 31, 2024 | ASHLEY, EUAN A | reporter.nih.gov |
| Investigating epigenetic mechanisms in Down syndrome using human cellular models | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $2,034,753 | April 5, 2023 | March 31, 2026 | BARRETT, LINDY ELISE | reporter.nih.gov |
| Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,034,388 | December 1, 2022 | August 31, 2024 | GEISSE, NICHOLAS ANDREW | reporter.nih.gov |
| Dissecting the role of tau glycosylation in Alzheimer's disease | NIH | National Institute on Aging | 2023 | $2,031,054 | April 15, 2023 | March 31, 2026 | WALCZAK, MACIEJ | reporter.nih.gov |
| Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,028,489 | September 1, 2021 | July 31, 2026 | MORAD, MARTIN | reporter.nih.gov |
| Functional analysis of mammalian midbody RNA in post-mitotic signaling functions | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,023,221 | September 16, 2021 | August 31, 2025 | SKOP, AHNA RENEE | reporter.nih.gov |
| A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,021,907 | December 15, 2019 | November 30, 2024 | ROSENFELD, MICHAEL G | reporter.nih.gov |
| Genetic Analysis of MicroRNA Functions in Skin Stem Cells In Vivo | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,013,300 | July 1, 2014 | November 30, 2025 | YI, RUI | reporter.nih.gov |
| iPSC-derived Neurovascular Organoids | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,012,834 | April 15, 2020 | March 31, 2026 | LIPPMANN, ETHAN | reporter.nih.gov |
| Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,008,113 | March 10, 2015 | June 30, 2024 | WU, JOSEPH C. | reporter.nih.gov |
| The role of APP in neurogenesis and AD in Down syndrome | NIH | National Institute on Aging | 2022 | $2,005,131 | September 15, 2022 | August 31, 2025 | LAZAROV, ORLY | reporter.nih.gov |
| Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,003,229 | April 1, 2020 | March 31, 2026 | ONG, SANG GING | reporter.nih.gov |
| Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome | NIH | National Institute of Mental Health | 2021 to 2023 | $1,997,858 | September 1, 2019 | September 30, 2024 | CUBELLS, JOSEPH F. | reporter.nih.gov |
| Generation of human skin organoids from pluripotency (Admin Supplement) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,996,696 | September 17, 2019 | August 31, 2025 | KOEHLER, KARL RUSSELL | reporter.nih.gov |
| Role of Siglec-1 in HIV Interactions with Microglia and Astrocytes | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,981,204 | July 15, 2020 | April 30, 2026 | SPEARMAN, PAUL W. | reporter.nih.gov |
| Human Microphysiological Model of Afferent Nociceptive Signaling | NIH | National Center for Advancing Translational Sciences | 2021 | $1,978,863 | September 26, 2019 | January 31, 2025 | MOORE, MICHAEL J | reporter.nih.gov |
| Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,948,211 | September 30, 2009 | July 31, 2025 | NEWBURGER, JANE W. | reporter.nih.gov |
| Define the effect of CLU SNP on the risk to Alzheimer's disease | NIH | National Institute on Aging | 2022 | $1,942,962 | August 1, 2022 | July 31, 2025 | SHI, YANHONG | reporter.nih.gov |
| A Novel Approach to Molecular Cell Pathologies of Human Down Syndrome and DS-AD | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,938,999 | September 12, 2017 | March 31, 2026 | LAWRENCE, JEANNE BENTLEY | reporter.nih.gov |
| Human iPSC model of Cerebro-Vascular Interactions in ADRD | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,931,965 | August 15, 2024 | July 31, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,931,388 | April 1, 2017 | March 31, 2024 | FINKBEINER, STEVEN M | reporter.nih.gov |
| Derivation of Functional Spermatogonia Stem Cells from Rhesus Macaque iPSCs | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $1,921,633 | September 9, 2019 | June 30, 2024 | EASLEY, CHARLES A. | reporter.nih.gov |
| Construction of the integrated human cortical organoids to investigate neurodevelopmental disorders | NIH | National Institute of Mental Health | 2021 to 2023 | $1,916,931 | September 9, 2019 | July 31, 2025 | PARK, IN-HYUN | reporter.nih.gov |
| The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND) | NIH | National Institute of Mental Health | 2021 to 2022 | $1,916,189 | September 10, 2018 | April 30, 2024 | MCDONOUGH, PATRICK M | reporter.nih.gov |
| Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,914,578 | January 17, 2020 | December 31, 2024 | DARBAR, DAWOOD | reporter.nih.gov |
| Assessing the effects of peripheral immune activation on the NVU following TBI using avascularized and perfused human blood/BBB model. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,914,338 | September 15, 2021 | August 31, 2023 | AGALLIU, DRITAN | reporter.nih.gov |
| Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,901,730 | August 15, 2013 | February 28, 2025 | OSTROWSKI, LAWRENCE E | reporter.nih.gov |
| Modulating microglial function to restore A-beta proteostasis in Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $1,894,783 | September 30, 2021 | August 31, 2024 | TOURTELLOTTE, WARREN G | reporter.nih.gov |
| UNDERSTANDING HEPATIC PROTEOSTASIS IN SYSTEMIC AMYLOID DISEASES | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,891,335 | July 14, 2020 | March 31, 2024 | WISEMAN, ROCKLAND LUKE | reporter.nih.gov |
| A 2D Intestinal Crypt Platform for Compound Screens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,888,698 | July 1, 2021 | July 31, 2025 | SIMS, CHRISTOPHER ELDRIDGE | reporter.nih.gov |
| Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $1,888,402 | September 8, 2023 | August 31, 2025 | ACKER, COREY | reporter.nih.gov |
| Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,887,016 | February 1, 2020 | January 31, 2026 | SCHWARTZ, ROBERT E | reporter.nih.gov |
| Genomic Studies in Charcot-Marie-Tooth Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,886,243 | September 15, 2019 | July 31, 2025 | ZUCHNER, STEPHAN | reporter.nih.gov |
| Microenvironmental Control of Liver Progenitor Cell Differentiation and Spatial Patterning | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,882,996 | April 15, 2021 | March 31, 2026 | UNDERHILL, GREGORY H | reporter.nih.gov |
| Effects of HSV-1 infection on neural progenitor cell biology in vitro and in vivo | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,871,397 | July 1, 2020 | April 30, 2026 | D'AIUTO, LEONARDO | reporter.nih.gov |
| CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,869,734 | April 1, 2014 | December 31, 2025 | TODD, PETER K | reporter.nih.gov |
| 3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma | NIH | National Cancer Institute | 2021 to 2024 | $1,863,510 | September 15, 2020 | June 30, 2025 | PELAEZ, DANIEL | reporter.nih.gov |
| Neuronal roles of Parkinsons Disease Vps13C in regulating autophagy and calcium dynamics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,856,046 | September 30, 2020 | January 31, 2026 | CARAVEOPISO, GABRIELA | reporter.nih.gov |
| Identifying the role of notch3 in brain pericyte function in health and Alzheimer's disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,838,781 | April 15, 2023 | March 31, 2026 | SHUSTA, ERIC V | reporter.nih.gov |
| Patient-derived Models of Synaptic Pruning in Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2023 | $1,832,595 | July 19, 2019 | April 30, 2025 | PERLIS, ROY H. | reporter.nih.gov |
| Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk | NIH | National Center for Advancing Translational Sciences | 2023 to 2024 | $1,827,318 | July 1, 2023 | June 30, 2025 | SIMS, CHRISTOPHER ELDRIDGE | reporter.nih.gov |
| Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,815,246 | April 1, 2014 | January 31, 2025 | ROSS, CHRISTOPHER A | reporter.nih.gov |
| Molecular dissection of synaptic dysfunction in mental disorders | NIH | National Institute of Mental Health | 2021 to 2024 | $1,815,127 | April 1, 2020 | January 31, 2026 | PAK, CHANGHUI | reporter.nih.gov |
| Targeting Tau Proteoforms in Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,815,043 | August 1, 2021 | July 31, 2024 | KARCH, CELESTE MARIE | reporter.nih.gov |
| Towards a preclinical model for overcoming infertility with induced pluripotent stem cells | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,802,832 | June 1, 2019 | May 31, 2025 | CLARK, AMANDER | reporter.nih.gov |
| Modeling Frontotemporal Dementia in Rhesus Macaques | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,789,771 | September 30, 2019 | May 31, 2026 | EMBORG, MARINA | reporter.nih.gov |
| 2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders | NIH | National Institute of Mental Health | 2021 to 2022 | $1,780,670 | August 17, 2018 | April 30, 2025 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Integrating epigenomics with DNA breathing dynamics for human non-coding disease variants | NIH | National Institute of Mental Health | 2021 to 2023 | $1,777,464 | April 8, 2019 | January 31, 2025 | DUAN, JUBAO | reporter.nih.gov |
| TAOK2 Kinase Signaling in Human Neural Stem Cell Development | NIH | National Institute of Mental Health | 2021 to 2024 | $1,777,371 | December 2, 2019 | November 30, 2025 | YADAV, SMITA | reporter.nih.gov |
| Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells | NIH | National Institute on Aging | 2021 to 2022 | $1,759,184 | September 30, 2018 | May 31, 2025 | ELLERBY, LISA M | reporter.nih.gov |
| Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2022 | $1,754,492 | September 30, 2018 | April 30, 2025 | FOSSATI, VALENTINA | reporter.nih.gov |
| Study of melanocyte lineage through SASH1 and associated proteins | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,751,055 | April 13, 2020 | March 31, 2026 | SHELLMAN, YIQUN G | reporter.nih.gov |
| Kindlin-3 signaling in platelets | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,742,425 | February 10, 2022 | January 31, 2026 | MA, YAN-QING | reporter.nih.gov |
| REGULATION OF SKELETAL MUSCLE DEVELOPMENT AND MAINTENANCE BY PROTEIN O-GLUCOSYLTRANSFERASE 1 (POGLUT1) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,740,283 | July 8, 2020 | June 30, 2025 | JAFAR-NEJAD, HAMED | reporter.nih.gov |
| Using hiPSCs to develop physiologically-relevant outer retina tissue mimetics | NIH | National Eye Institute | 2022 to 2024 | $1,738,353 | September 30, 2022 | August 31, 2025 | SINGH, RUCHIRA | reporter.nih.gov |
| Molecular underpinnings of Prader-Willi syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,733,926 | September 9, 2019 | June 30, 2025 | CARMICHAEL, GORDON G | reporter.nih.gov |
| Novel Regulation and Function of the lncRNA Gomafu in Human Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,731,019 | July 15, 2019 | May 31, 2025 | FENG, YUE | reporter.nih.gov |
| Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,730,750 | September 21, 2017 | August 31, 2024 | ROEHM, KEVIN | reporter.nih.gov |
| Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain | NIH | National Institute on Aging | 2021 to 2023 | $1,730,272 | September 1, 2019 | January 6, 2025 | ZHAO, JINYING | reporter.nih.gov |
| Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery | NIH | National Heart, Lung, and Blood Institute | 2022 | $1,728,439 | March 4, 2022 | February 28, 2023 | BUI, LYNNE A | reporter.nih.gov |
| ANKS1B haploinsufficiency in a novel brain disorder | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,727,744 | September 15, 2020 | August 31, 2025 | JORDAN, BRYEN ALEXANDER | reporter.nih.gov |
| Rescue of Lesch-Nyhan Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,719,066 | September 1, 2021 | June 30, 2026 | JINNAH, HYDER A | reporter.nih.gov |
| Functional consequences of FHC mutations in cardiac MyBPC | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,718,806 | February 1, 2013 | March 31, 2025 | STELZER, JULIAN | reporter.nih.gov |
| Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,713,966 | May 15, 2019 | February 29, 2024 | LEBAKKEN, CONNIE S | reporter.nih.gov |
| Functional analysis of autism risk genes during neural development using single cell seq | NIH | National Institute of Mental Health | 2021 to 2023 | $1,710,471 | March 15, 2019 | January 31, 2025 | GIRALDEZ, ANTONIO J | reporter.nih.gov |
| Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleus | NIH | National Institute on Aging | 2021 to 2023 | $1,709,738 | February 15, 2019 | November 30, 2024 | FROST, BESS | reporter.nih.gov |
| Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,707,540 | September 1, 2021 | August 31, 2024 | PARHAMI, FARHAD | reporter.nih.gov |
| Synergistic Enhancement of ER proteostasis, trafficking, and lysosomes as treatments for Dementia with Lewy bodies and Parkinson’s disease-dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,707,089 | August 15, 2024 | July 31, 2027 | MAZZULLI, JOSEPH R | reporter.nih.gov |
| Embryonic natural killer cell development and function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,702,824 | May 1, 2021 | April 30, 2025 | STURGEON, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,692,971 | April 1, 2020 | March 31, 2025 | CLEVELAND, DON W | reporter.nih.gov |
| Development and Evaluation of Rosette Array Technology for HumanNeurodevelopmental Toxicity Screening | NIH | National Institute of Environmental Health Sciences | 2022 to 2023 | $1,683,587 | January 1, 2022 | December 31, 2024 | ASHTON, RANDOLPH SCOTT | reporter.nih.gov |
| Regulation and function of hematopoietic stem cell niches | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,682,486 | March 1, 2000 | December 31, 2024 | GRITSMAN, KIRA | reporter.nih.gov |
| Defining the Mechanisms by Which MS4A Genes Regulate TREM2 in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2023 | $1,679,487 | September 1, 2019 | May 31, 2025 | KARCH, CELESTE MARIE | reporter.nih.gov |
| Development of HLA engineered universal vascular grafts from human iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,675,000 | August 1, 2021 | July 31, 2025 | QYANG, YIBING | reporter.nih.gov |
| Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,673,100 | September 30, 2018 | February 28, 2025 | YI, PENG | reporter.nih.gov |
| Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse Chimeras | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,671,510 | March 1, 2021 | December 31, 2026 | JIANG, PENG | reporter.nih.gov |
| Impact of coding and non-coding variation in progressive supranuclear palsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,664,308 | September 25, 2017 | July 31, 2023 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy | NIH | National Cancer Institute | 2021 to 2023 | $1,663,168 | July 3, 2018 | November 30, 2024 | YANG, JIN-MING | reporter.nih.gov |
| Stem cell-loaded microgels to treat discogenic low back pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,655,677 | September 27, 2021 | August 31, 2024 | SHEYN, DMITRIY | reporter.nih.gov |
| Protective role of Neuregulin-1 against cerebral malaria-induced neuronal injury and behavioral sequelae | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,644,196 | January 1, 2022 | December 31, 2027 | STILES, JONATHAN K. | reporter.nih.gov |
| Biomechanical Activation of Yap Induces Hematopoietic Stem Cell Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,632,318 | April 1, 2020 | March 31, 2026 | NORTH, TRISTA E. | reporter.nih.gov |
| A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling | NIH | National Institute of Mental Health | 2022 to 2023 | $1,630,701 | August 8, 2019 | October 31, 2024 | RYAN, STEVEN JOHN | reporter.nih.gov |
| Control of cardiomyocyte cell cycle by REST in heart failure and regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,630,521 | July 15, 2020 | September 30, 2023 | ZHOU, BIN | reporter.nih.gov |
| Epigenetic Pathology and Therapy in Huntington's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,621,733 | April 1, 2015 | May 31, 2025 | FRAENKEL, ERNEST | reporter.nih.gov |
| Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen species | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,614,963 | February 1, 2021 | January 31, 2026 | BERNDT, ANDRE | reporter.nih.gov |
| A multi-modular approach for human pluripotent stem cell-based liver regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,608,063 | September 15, 2020 | July 31, 2025 | GOUON-EVANS, VALERIE B | reporter.nih.gov |
| Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines | NIH | National Institute on Aging | 2022 to 2023 | $1,607,217 | September 30, 2018 | May 31, 2025 | GAITERI, CHRISTOPHER A. | reporter.nih.gov |
| Developmental Activation of the Inflammasome Controls Hematopoietic Stem Cell Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,599,382 | August 1, 2020 | July 31, 2025 | NORTH, TRISTA E. | reporter.nih.gov |
| Determining stathmin-2 function and potential as a therapeutic target in ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,595,758 | April 1, 2020 | March 31, 2025 | CLEVELAND, DON W | reporter.nih.gov |
| Mechanotransduction by Melusin in Cardiac Hypertrophy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,594,551 | July 1, 2020 | June 30, 2025 | SNIADECKI, NATHAN JOHN | reporter.nih.gov |
| Phosphoinositide signaling in glaucoma: rescue strategies for Lowe syndrome | NIH | National Eye Institute | 2021 to 2024 | $1,593,733 | June 1, 2021 | May 31, 2025 | SUN, YANG | reporter.nih.gov |
| Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis | NIH | National Institute on Aging | 2021 to 2023 | $1,593,459 | April 1, 2021 | June 30, 2023 | FLOWERS, SARAH ANN | reporter.nih.gov |
| Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines | NIH | National Institute on Aging | 2021 to 2022 | $1,590,436 | September 30, 2018 | August 31, 2022 | GAITERI, CHRISTOPHER A. | reporter.nih.gov |
| Precision models of ARX-associated neurodevelopmental disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,588,474 | June 1, 2019 | May 31, 2025 | HSIEH, JENNY | reporter.nih.gov |
| Editing CG and non-CG DNA methylation to identify genomic elements that regulate gene expression | NIH | National Human Genome Research Institute | 2021 to 2024 | $1,588,081 | September 10, 2021 | June 30, 2025 | GOODARZI, HANI | reporter.nih.gov |
| The Role of 3-Dimensional Genome Integrity In Cardiac Laminopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,585,451 | August 1, 2020 | May 31, 2025 | KARAKIKES, IOANNIS | reporter.nih.gov |
| Cellular and Molecular Mechanisms of Brain Dysfunction in NF1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,581,350 | April 15, 2020 | January 31, 2025 | YANG, NAN | reporter.nih.gov |
| Identification of Genetic and Molecular Bases of Derived Phenotypes in Primate Brain Development | NIH | National Human Genome Research Institute | 2021 to 2023 | $1,574,253 | May 16, 2023 | June 30, 2024 | SESTAN, NENAD | reporter.nih.gov |
| Dynamic Biomaterial Design to Probe the Cellular Response to Fibrotic Stiffening | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,574,063 | August 15, 2021 | July 31, 2025 | BLAU, HELEN M | reporter.nih.gov |
| An Alternative Isoform of RRM2B as a Genetic Modifier in Huntington's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,567,356 | July 1, 2020 | April 30, 2026 | SEONG, IHN SIK | reporter.nih.gov |
| Effects of ABCD1 Deficiency on Endothelial Function and Permeability to Leukocytes in Cerebral X-linked Adrenoleukodystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,567,356 | September 1, 2020 | June 30, 2025 | MUSOLINO, PATRICIA L | reporter.nih.gov |
| Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,560,000 | December 1, 2019 | November 30, 2025 | BARMADA, SAMI | reporter.nih.gov |
| HNF1A in human endocrine cell development and function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,556,784 | July 20, 2020 | June 30, 2025 | GADUE, PAUL J | reporter.nih.gov |
| Epigenomic, transcriptional and cellular dissection of Alzheimer's variants | NIH | National Institute on Aging | 2021 | $1,552,886 | June 15, 2018 | May 31, 2022 | KELLIS, MANOLIS | reporter.nih.gov |
| IDOL and dyslipidemia in cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,547,876 | September 1, 2019 | July 31, 2024 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Biodistribution and PK modeling of rat vs. human systems | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,543,653 | September 11, 2020 | February 28, 2025 | SHULER, MICHAEL L | reporter.nih.gov |
| Role of VGLL1 in human placental development and trophoblast specification | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,539,133 | February 1, 2019 | January 31, 2025 | SONCIN, FRANCESCA | reporter.nih.gov |
| Defining the Human Articular Chondrocyte Lineage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,537,754 | April 1, 2019 | February 28, 2025 | CRAFT, APRIL MARIE | reporter.nih.gov |
| Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,528,574 | January 1, 2020 | December 31, 2024 | MESTRONI, LUISA | reporter.nih.gov |
| Modulating an Astrocyte Hemichannel to Delay Spatial and Temporal Progression in ALS. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,527,714 | July 1, 2020 | June 30, 2025 | MARAGAKIS, NICHOLAS J | reporter.nih.gov |
| Mechanism of apicosome-driven lumen formation during human and mouse embryogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,525,138 | September 1, 2020 | June 30, 2025 | TANIGUCHI, KENICHIRO | reporter.nih.gov |
| Neurxtem Neural Organoid Human Platform Development for Substance and Opioid Use Disorders | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,516,917 | May 1, 2020 | January 31, 2023 | ANAND, RENE | reporter.nih.gov |
| Senescence-Induced Progression of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $1,508,646 | September 15, 2020 | May 31, 2026 | WANG, GAVIN YONG | reporter.nih.gov |
| One-compound, one-islet: A high-throughput platform for small-molecule discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,507,666 | September 20, 2019 | July 31, 2023 | WAGNER, BRIDGET K | reporter.nih.gov |
| Microscale models of inflammation and its resolution | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,504,556 | April 25, 2018 | March 31, 2024 | BEEBE, DAVID J | reporter.nih.gov |
| Leveraging Human iPSC-derived beta-cells to Probe Antigen Specificity of Anti-islet Memory T Cells in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,503,173 | February 1, 2023 | July 31, 2025 | TEYTON, LUC | reporter.nih.gov |
| Fine-mapping psychiatricdisease variants that affect post-transcriptional gene regulation | NIH | National Institute of Mental Health | 2021 to 2022 | $1,501,550 | July 5, 2021 | June 30, 2024 | KNOWLES, DAVID ARTHUR | reporter.nih.gov |
| Combinatorial Actions of Genetic Variants and Gender Bias of Alzherimer's Disease | NIH | National Institute on Aging | 2021 | $1,501,262 | September 30, 2017 | May 31, 2023 | ROSENFELD, MICHAEL G | reporter.nih.gov |
| An integrative cellular blueprint of vertebrate tissue development | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $1,500,000 | September 15, 2018 | August 31, 2024 | TRAVER, DAVID | reporter.nih.gov |
| Chromatin dynamics in the regulation of herpes simplex virus 1 gene expression. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,498,123 | May 11, 2020 | April 30, 2025 | SCHANG, LUIS M. | reporter.nih.gov |
| HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,495,522 | May 17, 2021 | March 31, 2024 | REES, STEVEN D | reporter.nih.gov |
| Uncover the role of glia-neuron crosstalk in hereditary spastic paraplegias | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,491,787 | June 1, 2020 | May 31, 2026 | LI, XUE-JUN | reporter.nih.gov |
| A micromachining fluidic cantilever for single cell advanced patch clamping and cellular characterization using atomic force microscopy | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,485,554 | May 1, 2022 | April 30, 2025 | CHAND, AMI | reporter.nih.gov |
| Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,482,032 | August 1, 2018 | April 30, 2025 | SORSCHER, ERIC J | reporter.nih.gov |
| Gene expression profiling of IPSC derived neurons in Autism Spectrum Disorder | NIH | National Institute of Mental Health | 2021 to 2022 | $1,478,393 | April 6, 2018 | December 31, 2022 | HALLMAYER, JOACHIM F | reporter.nih.gov |
| Novel epigenetic mechanisms in neuronal development and cognitive function | NIH | National Institute of Mental Health | 2021 to 2022 | $1,473,810 | August 10, 2012 | August 31, 2023 | POMEROY, SCOTT LOREN | reporter.nih.gov |
| Modular Platform for Combinatorial Epigenome Manipulation | NIH | National Human Genome Research Institute | 2021 to 2022 | $1,469,440 | January 1, 2018 | December 31, 2023 | ADAMS, MARK D | reporter.nih.gov |
| Transcriptional Factor SOX2, LncRNA HBL1, microRNA1 and PRC2 Epigenetic Complex Compose a Network to Orchestrate Cardiac Differentiation from Human Pluripotent Stem Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,465,719 | July 1, 2019 | June 30, 2025 | YANG, LEI | reporter.nih.gov |
| Genetic Pathways in Ceramide-Associated Lipotoxic Cardiomyopathy and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,462,500 | December 10, 2019 | May 31, 2024 | BODMER, ROLF | reporter.nih.gov |
| Tuberous Sclerosis Complex Patients iPSC-derived NPCs and NCCs as Human Model Systems to Identify Novel Targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,460,553 | June 15, 2019 | May 30, 2025 | RAMESH, VIJAYA | reporter.nih.gov |
| Novel pro-healing scaffolds for cell therapies | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,460,064 | May 1, 2020 | February 28, 2025 | CRISA, LAURA | reporter.nih.gov |
| Beyond Pseudotime: Enhanced Single-cell Genomics Tools for Understanding the Temporal Dynamics of Development and Disease | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,458,360 | September 1, 2020 | August 31, 2025 | CUSANOVICH, DARREN A | reporter.nih.gov |
| Identifying mTOR Dependent Periods During Brain Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,451,078 | September 1, 2020 | August 31, 2024 | IHRIE, REBECCA A | reporter.nih.gov |
| Functional and molecular basis of ineffective erythropoiesis in SF3B1-mutant myelodysplastic syndromes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,444,574 | June 1, 2020 | May 31, 2025 | BRADLEY, ROBERT K | reporter.nih.gov |
| Engineered Human Heart Slice for Testing Drug-Induced Arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,436,457 | April 1, 2020 | March 31, 2024 | BOHELER, KENNETH RICHARD | reporter.nih.gov |
| Altered inflammatory response associated with acquired DNMT3A mutations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,432,778 | May 1, 2021 | September 30, 2022 | BYUN, MINJI | reporter.nih.gov |
| Predicting the multi-omic impact of psychiatric GWAS associations | NIH | National Institute of Mental Health | 2021 to 2022 | $1,431,911 | February 1, 2019 | June 30, 2022 | HUCKINS, LAURA MARIANNE | reporter.nih.gov |
| Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis | NIH | National Institute on Aging | 2021 | $1,431,396 | June 15, 2015 | July 29, 2023 | CAI, DONGMING | reporter.nih.gov |
| SMCHD1 Pathways as Candidate Targets for FSHD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,429,596 | April 25, 2014 | June 30, 2025 | TAPSCOTT, STEPHEN J | reporter.nih.gov |
| Harnessing stem cells and synthetic gene circuits to repair glomerular injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $1,425,761 | September 1, 2023 | August 31, 2026 | MUSAH, SAMIRA | reporter.nih.gov |
| Alzheimer's disease-replicated brain microphysiological system to model AD physiopathology and its influenceon gliovasculature and immune system | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,423,803 | February 1, 2021 | January 31, 2026 | YUN, YEOHEUNG | reporter.nih.gov |
| Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | NIH | National Cancer Institute | 2021 to 2023 | $1,422,549 | April 1, 2021 | August 31, 2023 | KROETZ, DEANNA L | reporter.nih.gov |
| Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,417,766 | August 1, 2020 | May 31, 2025 | CHEN, ELIZABETH H | reporter.nih.gov |
| Molecular Mechanisms of Epilepsy-Causing Mutations in IKM channels: anti-epileptic effect of Lipophilic compounds. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,409,055 | January 1, 2020 | March 31, 2025 | BARRO-SORIA, RENE | reporter.nih.gov |
| Use of IPSC to define role of astrocytes in specifying risk for onset of cerebral adrenoleukodystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,404,090 | July 1, 2021 | June 30, 2026 | SINGH, JASPREET | reporter.nih.gov |
| DNA repair pathway choice mediates somatic cell reprogramming | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,401,318 | September 1, 2020 | May 31, 2025 | EGLI, DIETER MEINRAD | reporter.nih.gov |
| Mechanisms of mTOR-independent axon growth and guidance defects in TSC2 mutant human neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,400,852 | May 1, 2020 | April 30, 2026 | GOMEZ, TIMOTHY M | reporter.nih.gov |
| Define the mechanisms of aortopathy in bicuspid aortic valve patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,393,504 | April 13, 2018 | March 31, 2024 | YANG, BO | reporter.nih.gov |
| Pathogenesis of Emery-Dreifuss Muscular Dystrophy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,385,343 | May 15, 2003 | June 30, 2026 | WORMAN, HOWARD J | reporter.nih.gov |
| Decoding the Spatial Grammar of Developmental Signaling | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $1,383,800 | September 20, 2023 | August 31, 2026 | LORD, NATHAN DALE | reporter.nih.gov |
| Transcriptional regulation of cardiac pathological remodeling by REV-ERBα | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,381,290 | May 8, 2019 | April 30, 2025 | ZHANG, LILEI | reporter.nih.gov |
| Human pluripotent stem cells for the study of gastrointestinal dysmotility | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,380,385 | April 15, 2020 | March 31, 2025 | FATTAHI, FARANAK | reporter.nih.gov |
| Distinct contributions of mesenchymal cell niches in the therapeutic potential of the hedgehog pathway in triple negative breast cancer | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,379,794 | August 1, 2020 | July 31, 2025 | DOMENECH, MARIBELLA | reporter.nih.gov |
| Role of SUMOylation in Mitochondrial/Synaptic Axis Dysfunction Induced by Abnormal Tau in FTD | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,376,782 | September 19, 2023 | August 31, 2028 | QUINZII, CATARINA M. | reporter.nih.gov |
| Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,375,266 | March 23, 2020 | February 28, 2025 | ZWAKA, THOMAS P. | reporter.nih.gov |
| Developing a microfluidic human neurovascular unit system to investigate genetic and age-related risk factors in Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2024 | $1,372,731 | September 30, 2022 | August 31, 2025 | SPROUL, ANDREW ALEXANDER | reporter.nih.gov |
| Protein Homeostasis and Proteotoxicity Mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,365,060 | February 1, 2015 | May 31, 2026 | LIN, JONATHAN | reporter.nih.gov |
| Gene-environment interactions in epithelial morphogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,364,784 | April 9, 2019 | March 31, 2026 | XIA, YING | reporter.nih.gov |
| Molecular mechanisms and genetic drivers of reciprocal genomic disorders | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,364,240 | September 15, 2018 | June 30, 2024 | TALKOWSKI, MICHAEL E | reporter.nih.gov |
| Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,364,129 | January 1, 2019 | December 31, 2024 | ENTCHEVA, EMILIA | reporter.nih.gov |
| Quantitative Cu-Homeostasis in Live Mammalian Cells at the Single-Molecule Level | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,362,518 | August 15, 2019 | May 31, 2025 | CHEN, TAI-YEN | reporter.nih.gov |
| Microbiome-triggered reprogramming and mutation of colon epithelial cells leading to tumor stem-like cells | NIH | National Cancer Institute | 2021 to 2023 | $1,358,184 | April 1, 2019 | March 31, 2025 | HUYCKE, MARK M | reporter.nih.gov |
| Multi-scale modeling of inherited pediatric cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,355,405 | September 1, 2017 | January 31, 2023 | PARKER, KEVIN KIT | reporter.nih.gov |
| Cardiac Revascularization with Direct Reprogramming Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,347,408 | February 12, 2020 | January 31, 2025 | YOON, YOUNG-SUP | reporter.nih.gov |
| Study of Selective Cell and System Vulnerability in Alzheimer's Disease | NIH | National Institute on Aging | 2022 | $1,344,626 | September 1, 2022 | April 30, 2023 | LI, YUN | reporter.nih.gov |
| Stem cell-based tissue engineering for myotendinous junction modeling and repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,344,008 | April 1, 2020 | January 31, 2026 | SUZUKI, MASATOSHI | reporter.nih.gov |
| Id3 and VSMC in Murine and Human Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,342,034 | August 28, 2019 | June 30, 2023 | MCNAMARA, COLEEN A | reporter.nih.gov |
| Immunomyoblasts in muscle regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,336,330 | May 10, 2021 | April 30, 2024 | KUANG, SHIHUAN | reporter.nih.gov |
| Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,336,300 | September 1, 2019 | August 31, 2024 | GERSBACH, CHARLES A. | reporter.nih.gov |
| Loss-of-Function Analyses of SETD1A in Human Neural Models | NIH | National Institute of Mental Health | 2021 to 2022 | $1,335,252 | July 1, 2021 | April 30, 2023 | PANG, ZHIPING P. | reporter.nih.gov |
| Common schizophrenia variants functioning in developmental human cortical interneurons | NIH | National Institute of Mental Health | 2023 to 2024 | $1,324,075 | July 1, 2023 | August 29, 2024 | CHUNG, SANGMI | reporter.nih.gov |
| Epigenetic control of muscle stem cell function by PASK-Wdr5 signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,322,588 | February 25, 2020 | November 30, 2025 | KIKANI, CHINTAN K | reporter.nih.gov |
| Functional genetics of tissue factor in bleeding and thrombotic risk | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $1,312,500 | September 16, 2019 | August 31, 2025 | SCHULMAN, SOL | reporter.nih.gov |
| Cellular and Molecular Basis of Human Primordial Germ Cell Specification | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,311,481 | December 20, 2014 | April 30, 2026 | CLARK, AMANDER | reporter.nih.gov |
| Elucidating the FOXF1 gene regulatory network in human alveologenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,307,495 | February 15, 2023 | January 31, 2028 | GU, MINGXIA | reporter.nih.gov |
| Identification of therapeutic targets for leukemia stem cells in AML-iPSC models | NIH | National Cancer Institute | 2021 to 2022 | $1,306,690 | March 1, 2018 | February 28, 2023 | PAPAPETROU, EIRINI | reporter.nih.gov |
| A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $1,305,180 | September 15, 2018 | May 31, 2025 | TEICH, ANDREW FRANKLIN | reporter.nih.gov |
| The Spatiotemporal Landscape of the Human Brain Epitranscriptome | NIH | National Institute of Mental Health | 2021 to 2022 | $1,303,579 | July 1, 2018 | March 31, 2025 | MASON, CHRISTOPHER EDWARD | reporter.nih.gov |
| Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,302,196 | July 1, 2020 | March 31, 2026 | SWANSTROM, RONALD I | reporter.nih.gov |
| Zika Virus Capsid Protein Mediated Blockage of host microRNA machinery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,302,099 | May 1, 2019 | February 28, 2025 | ZHAO, ZHEN | reporter.nih.gov |
| Functional drug fingerprinting with all-optical electrophysiology | NIH | National Institute of Mental Health | 2022 | $1,296,058 | September 20, 2019 | June 30, 2023 | HARWOOD, BENJAMIN NATHANIEL | reporter.nih.gov |
| Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons. | NIH | National Institute on Aging | 2021 to 2022 | $1,294,076 | September 30, 2018 | May 31, 2025 | YOUNG, JESSICA ELAINE | reporter.nih.gov |
| Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomics | NIH | National Institute on Aging | 2021 to 2022 | $1,292,532 | September 30, 2018 | May 31, 2023 | KAMPMANN, MARTIN | reporter.nih.gov |
| Tissue Chip Models for Cardiovascular Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,275,636 | February 20, 2020 | January 31, 2025 | SETHU, PALANIAPPAN | reporter.nih.gov |
| Skeletal Muscle Stem Cells Derived from Teratomas | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,274,254 | May 1, 2019 | April 30, 2024 | KYBA, MICHAEL | reporter.nih.gov |
| A High Content Chemical Screen to Identify the Drug Candidates Promoting Human Beta Cell Proliferation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,271,250 | April 1, 2020 | February 29, 2024 | CHEN, SHUIBING | reporter.nih.gov |
| Astrocyte dysfunction in idiopathic autism | NIH | National Institute of Mental Health | 2021 to 2023 | $1,271,250 | July 1, 2019 | April 30, 2025 | COLAK, DILEK | reporter.nih.gov |
| Metabolism of AMD iPSC-derived RPE | NIH | National Eye Institute | 2022 to 2024 | $1,268,628 | September 30, 2022 | August 31, 2025 | CHAO, JENNIFER RAYMING | reporter.nih.gov |
| Molecular Quiescence and Cardiomyocyte Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,267,500 | April 5, 2020 | March 31, 2024 | LEE, RICHARD T | reporter.nih.gov |
| Highly Specific ZFN-Based HSC Gene Editing Therapies Identified By In Vivo Barcode Nanoparticle Screens and Rationally Designed mRNA | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $1,264,949 | September 16, 2019 | August 31, 2024 | DAHLMAN, JAMES | reporter.nih.gov |
| IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,260,063 | July 1, 2019 | June 30, 2024 | JOHNSON, F. BRAD | reporter.nih.gov |
| Translational control in neurogenesis by ZNF804A | NIH | National Institute of Mental Health | 2021 to 2024 | $1,239,705 | April 1, 2020 | January 30, 2026 | MAO, YINGWEI | reporter.nih.gov |
| Functional 3D tissue-engineering models of the cerebrovasculature incorporating stem cell-derived brain microvascular endothelial cells, pericytes, and astrocytes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,233,416 | April 1, 2019 | December 31, 2024 | SEARSON, PETER C | reporter.nih.gov |
| Identification of the specific risk allele responsible for oxidative stress in ARMS2/HTRA1-related AMD | NIH | National Eye Institute | 2022 to 2024 | $1,225,973 | September 30, 2022 | August 31, 2025 | TSANG, STEPHEN H | reporter.nih.gov |
| A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $1,222,769 | July 1, 2022 | June 30, 2023 | KIM, DEOK-HO | reporter.nih.gov |
| In vivo development and reactivity of human autoreactive T cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,215,000 | November 15, 2018 | October 31, 2024 | CREUSOT, REMI J | reporter.nih.gov |
| Investigating the co-transcriptional impact of genetic variation on gene regulation and disease | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,215,000 | May 1, 2019 | April 30, 2024 | LI, YANG | reporter.nih.gov |
| Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,213,868 | September 25, 2017 | August 31, 2024 | RADEMAKERS, ROSA | reporter.nih.gov |
| Uncovering the Genetic Mechanisms Behind Joint-Specific Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,202,184 | April 1, 2018 | January 31, 2024 | CAPELLINI, TERENCE D | reporter.nih.gov |
| Modeling Inherited Neurodevelopmental Disorders with Human Induced Pluripotent Stem Cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,198,680 | July 1, 2019 | April 30, 2024 | JINNAH, HYDER A | reporter.nih.gov |
| Mechanistic insights into the role of mitochondrial iron in doxorubicin-induced cardiomyopathy using human induced pluripotent stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,196,250 | March 15, 2020 | February 28, 2025 | ARDEHALI, HOSSEIN | reporter.nih.gov |
| Live imaging of stem cell dynamics in cornea regeneration | NIH | National Eye Institute | 2021 to 2023 | $1,194,375 | September 1, 2019 | July 31, 2025 | ROMPOLAS, PANTELEIMON | reporter.nih.gov |
| Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,193,484 | March 9, 2018 | February 29, 2024 | GUHA, CHANDAN | reporter.nih.gov |
| Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $1,192,518 | July 1, 2023 | June 30, 2025 | TSE, HUBERT M | reporter.nih.gov |
| Development of Mass Spectrometry Strategies to Decipher Dynamic Lysosomal Dysfunctions in Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,188,229 | April 15, 2021 | August 31, 2024 | HAO, LING | reporter.nih.gov |
| Depositing Data Generated from Drug Test on microJoint Model into the Microphysiology Systems Database | NIH | National Center for Advancing Translational Sciences | 2021 | $1,186,687 | August 20, 2017 | June 30, 2023 | LIN, HANG | reporter.nih.gov |
| Transcriptional and Epigenetic Control of Pluripotency and Self-Renewal by Honey Bee Royalactin and its human structural analog | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,186,613 | August 15, 2020 | January 18, 2024 | WANG, KEVIN CHUN-KAI | reporter.nih.gov |
| Gene Editing vs Neutrophil Elastase Inhibitors for Treatment of ELANE Associated Neutropenia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,184,117 | April 15, 2020 | March 31, 2025 | DALE, DAVID CHANDLER | reporter.nih.gov |
| Subcellular RNA-Proteome Mapping in Subtype- and Circuit-Specific Growth Cones: Development, Cell Biology, Disease, and Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,183,000 | September 30, 2017 | July 31, 2024 | MACKLIS, JEFFREY D | reporter.nih.gov |
| Multicomponent solutions for the preservation of cell therapy products | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,174,641 | August 3, 2017 | June 30, 2025 | HUBEL, ALLISON | reporter.nih.gov |
| Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | NIH | National Eye Institute | 2022 to 2024 | $1,174,621 | September 30, 2022 | August 31, 2025 | FERRINGTON, DEBORAH ANN | reporter.nih.gov |
| Functional drug fingerprinting with all-optical electrophysiology | NIH | National Institute of Mental Health | 2023 to 2024 | $1,171,510 | September 20, 2019 | October 31, 2025 | HARWOOD, BENJAMIN NATHANIEL | reporter.nih.gov |
| Inhibiting Cell Death for Protecting Cardiac Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | July 1, 2020 | June 30, 2024 | ZHU, HUA | reporter.nih.gov |
| AMPK/SIRT1/PGC-1α, a critical pathway in dry AMD | NIH | National Eye Institute | 2021 to 2023 | $1,169,908 | April 1, 2019 | March 31, 2025 | GOLESTANEH, NADY | reporter.nih.gov |
| Synaptic Pruning and Complement Gene in Schizophrenia: Imaging & Cellular Studies | NIH | National Institute of Mental Health | 2021 to 2022 | $1,167,870 | July 12, 2018 | April 30, 2024 | PRASAD, KONASALE M | reporter.nih.gov |
| Selective interactome vulnerability across the Alzheimer’s disease spectrum | NIH | National Institute on Aging | 2021 | $1,162,517 | May 15, 2021 | April 30, 2023 | CHIOSIS, GABRIELA | reporter.nih.gov |
| Cellular and Molecular Mechanisms of FUS-related ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,161,739 | April 15, 2013 | January 31, 2025 | PANDEY, UDAI B | reporter.nih.gov |
| CD4 T cell stemness and inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,157,862 | September 1, 2020 | May 31, 2025 | HARRINGTON, LAURIE ELLEN | reporter.nih.gov |
| Tead1 and Cardiac Adaptation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,150,020 | July 1, 2019 | June 30, 2025 | MOULIK, MOUSUMI | reporter.nih.gov |
| Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma | NIH | National Eye Institute | 2021 to 2022 | $1,149,852 | July 1, 2019 | June 30, 2024 | ETHIER, C ROSS | reporter.nih.gov |
| Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models | NIH | National Center for Advancing Translational Sciences | 2021 | $1,149,180 | July 21, 2017 | June 30, 2023 | WIKSWO, JOHN PETER | reporter.nih.gov |
| Mechanisms of TL1A-driven Paneth Cell dysfunction in IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,147,500 | January 1, 2020 | December 31, 2024 | TARGAN, STEPHAN R. | reporter.nih.gov |
| Mitochondria and TFAM in Osteoblast Biology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,147,343 | July 15, 2019 | November 30, 2024 | SCHIPANI, ERNESTINA | reporter.nih.gov |
| Neuroinflammation and vascular development in GMH | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $1,143,982 | August 1, 2023 | July 31, 2028 | HUANG, ERIC J | reporter.nih.gov |
| Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,142,172 | July 1, 2023 | June 30, 2025 | GASKILL, PETER JESSE | reporter.nih.gov |
| Modeling Hepatoblastoma using pluripotent stem cell derived hepatocyte-like cells | NIH | National Cancer Institute | 2021 to 2023 | $1,140,447 | August 19, 2019 | July 31, 2025 | SCHWARTZ, ROBERT E | reporter.nih.gov |
| SPOTs: Optical Technologies for Instantly Quantifying Multicellular Response Profiles | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,137,513 | June 1, 2020 | March 31, 2025 | CHIOU, PEI-YU | reporter.nih.gov |
| Lung epithelial cell specification in human pluripotent stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,135,872 | April 1, 2019 | March 31, 2023 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| Gene Regulatory Non-Coding RNAs in the Human Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,120,487 | August 17, 2019 | July 31, 2023 | MOSKOWITZ, IVAN PAUL | reporter.nih.gov |
| R01 Renewal: Collaboration of chromatin remodeling and signaling pathways in pluripotency | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,119,364 | July 10, 2015 | July 31, 2024 | SRIDHARAN, RUPA | reporter.nih.gov |
| Translational Epigenetics with XIST: Silencing Trisomy in Human Organoid and Mouse Models of Down Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,118,382 | September 19, 2018 | June 30, 2025 | LAWRENCE, JEANNE BENTLEY | reporter.nih.gov |
| Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease | NIH | National Institute on Aging | 2021 to 2022 | $1,117,111 | September 30, 2018 | May 31, 2024 | DAVTYAN, HAYK | reporter.nih.gov |
| Single Cell Transcriptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain | NIH | National Institute on Drug Abuse | 2021 | $1,105,894 | November 5, 2020 | January 31, 2022 | CHENG, CHRISTINE | reporter.nih.gov |
| Brain-region-specific humanized cortical interneuron mice | NIH | National Institute of Mental Health | 2023 to 2024 | $1,102,988 | July 1, 2023 | August 29, 2024 | CHUNG, SANGMI | reporter.nih.gov |
| CFTR modulates innate immune response in biliary epithelium: Role in the pathogenesis and treatment of Cystic-Fibrosis-related liver disease. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,093,088 | May 1, 2013 | July 31, 2024 | STRAZZABOSCO, MARIO | reporter.nih.gov |
| Epigenetic Regulation of Chondrogenesis and Cartilage Development | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,092,641 | March 5, 2021 | February 28, 2024 | WU, CHIA-LUNG | reporter.nih.gov |
| Dysregulation of p97/VCP disease mutants in IBM and FTLD-U | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,088,809 | July 1, 2018 | April 30, 2024 | CHOU, TSUI-FEN | reporter.nih.gov |
| Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $1,086,082 | May 1, 2019 | November 30, 2021 | MAHLEY, ROBERT W. | reporter.nih.gov |
| Analysis of non-canonical functions of microRNAs | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,085,053 | March 2, 2023 | February 28, 2025 | CIFUENTES, DANIEL | reporter.nih.gov |
| Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,080,500 | May 1, 2020 | April 30, 2025 | ZHU, JIEQING | reporter.nih.gov |
| Signal Integration During Eye Formation | NIH | National Eye Institute | 2021 to 2023 | $1,077,805 | September 1, 2020 | August 31, 2025 | BROWN, NADEAN L | reporter.nih.gov |
| Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,076,177 | August 1, 2021 | July 31, 2025 | CANTOR, ALAN B. | reporter.nih.gov |
| Genetic Signals in Ventricular Hypertrophy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,071,326 | February 1, 2007 | July 31, 2024 | SEIDMAN, JONATHAN G | reporter.nih.gov |
| Regulation of cardiac power output in health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,070,114 | April 1, 2018 | March 31, 2024 | GREENBERG, MICHAEL J | reporter.nih.gov |
| A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,065,481 | September 1, 2017 | July 31, 2023 | GEORGE, STEVEN CARL | reporter.nih.gov |
| DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,063,408 | May 15, 2020 | April 30, 2024 | KIM, DEOK-HO | reporter.nih.gov |
| HIF-2alpha, a Novel Regulator of Osteoblastogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,057,667 | January 11, 2019 | December 31, 2023 | SCHIPANI, ERNESTINA | reporter.nih.gov |
| Role of L-type Calcium Channels in Human Interneuron Migration and Integration | NIH | National Institute of Mental Health | 2021 to 2022 | $1,055,351 | August 10, 2018 | April 30, 2024 | PASCA, SERGIU | reporter.nih.gov |
| T-Cell Targeting for GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,054,732 | August 1, 1995 | December 31, 2023 | BLAZAR, BRUCE R | reporter.nih.gov |
| Mechanisms of Hedgehog Regulation of Intestinal Villus Morphogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,053,000 | March 1, 2019 | February 28, 2025 | WALTON, KATHERINE DEMPSEY | reporter.nih.gov |
| Function of MLL in transcription regulation | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,052,562 | April 1, 2009 | April 30, 2025 | DOU, YALI | reporter.nih.gov |
| Distal enhancers controlling motor neuron gene expression program | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,043,568 | December 1, 2018 | November 30, 2023 | WICHTERLE, HYNEK | reporter.nih.gov |
| A Genetically Engineered Human Fetal Liver Niche as a Novel Platform for Biomanufacturing of Hematopoietic Stem Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,037,088 | July 1, 2019 | June 30, 2025 | EBRAHIMKHANI, MO REZA | reporter.nih.gov |
| Essential requirements of Eif4a3 in brain development and disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,035,767 | June 1, 2013 | May 31, 2025 | SILVER, DEBRA | reporter.nih.gov |
| Transcription Factor Control of Liver Development and Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,032,346 | January 1, 2020 | June 30, 2024 | CIRILLO, LISA A | reporter.nih.gov |
| Viscoelastic Properties of Normal and OA Chondrons | NIH | National Institute on Aging | 2021 to 2022 | $1,027,495 | January 1, 1998 | March 31, 2025 | GUILAK, FARSHID | reporter.nih.gov |
| A Neurovascular Microphysiological System | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,020,468 | July 1, 2019 | June 30, 2024 | MURPHY, WILLIAM L. | reporter.nih.gov |
| Identifying therapeutic strategies for the multisystem genetic disorder Pseudoxanthoma Elasticum | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,015,872 | February 1, 2020 | November 30, 2024 | DEB, ARJUN | reporter.nih.gov |
| Structure-Function Analysis of Sarcospan | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,015,872 | September 24, 2001 | May 31, 2025 | CROSBIE, RACHELLE HOPE | reporter.nih.gov |
| Modeling Anthracycline-Induced Cognitive Impairment Using iPSC-Derived Brain-On-Chips | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,003,658 | August 5, 2014 | March 31, 2023 | WU, JOSEPH C. | reporter.nih.gov |
| Microfluidic cell squeezing platform for the transdifferentiation of somatic cells for efficient generation of a cell replacement therapy for Parkinsons Disease | NIH | National Institute of General Medical Sciences | 2022 | $1,001,356 | March 14, 2022 | December 15, 2022 | BRIDGEN, DEVIN | reporter.nih.gov |
| RIGERR: Resources for Investigating Genetic and Epigenetic Regulation of Renal Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $999,999 | September 15, 2022 | July 31, 2027 | LIANG, MINGYU | reporter.nih.gov |
| Pioneer transcription factors in aging and neurodegeneration | NIH | National Institute on Aging | 2021 to 2023 | $994,263 | August 15, 2021 | July 31, 2023 | WEBB, ASHLEY E | reporter.nih.gov |
| Mechanisms of Shear Induction of Blood-Brain Barrier Phenotypes in Human iPSC-derived Brain Endothelial Progenitors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $993,822 | February 15, 2019 | January 31, 2025 | PALECEK, SEAN P | reporter.nih.gov |
| 1/2 Cross modal integration of molecular and physiological networks in ASD | NIH | National Institute of Mental Health | 2021 | $993,129 | September 21, 2017 | July 31, 2023 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Study and Treatment of Mitochondrial DNA Depletion Syndrome 3 Using iPSCs | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $989,672 | January 15, 2019 | December 31, 2023 | DUNCAN, STEPHEN A | reporter.nih.gov |
| Targeting PTEN to ameliorate muscular dystrophy in a mouse model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $989,224 | January 27, 2022 | December 31, 2024 | KUANG, SHIHUAN | reporter.nih.gov |
| Chaperone-mediated Autophagy and Synaptic Dysfunction in Parkinson's Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $986,946 | August 1, 2018 | May 31, 2023 | MAO, ZIXU | reporter.nih.gov |
| Functional consequences of mutations in spliceosomal small nuclear RNAs | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $968,639 | August 1, 2019 | July 31, 2024 | PADGETT, RICHARD A | reporter.nih.gov |
| Thyroid Hormone Signaling in Human Hepatocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $965,058 | April 1, 2019 | November 14, 2022 | HOLLENBERG, ANTHONY N | reporter.nih.gov |
| CRISPR-Cas9 editing in C9orf72 patient derived iPSC | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $961,200 | July 1, 2020 | June 30, 2025 | CLELLAND, CLAIRE | reporter.nih.gov |
| Transplantation of Testis Stem Cells in Large Animals | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $956,232 | September 1, 2013 | February 28, 2026 | DOBRINSKI, INA | reporter.nih.gov |
| PLT+ Characterization and IND-Enabling Studies | NIH | National Heart, Lung, and Blood Institute | 2021 | $952,100 | April 1, 2016 | June 30, 2023 | DYKSTRA, BRADFORD | reporter.nih.gov |
| Non-Invasive Tracking of Genome-Corrected iPS cells in ALS | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $950,463 | September 1, 2019 | July 31, 2025 | BULTE, JEFF W. | reporter.nih.gov |
| Determining the role of CLN3 in the eye | NIH | National Eye Institute | 2021 to 2022 | $949,115 | April 1, 2019 | January 31, 2025 | SINGH, RUCHIRA | reporter.nih.gov |
| Dynamic double network hydrogel for generating pancreatic organoids from induced pluripotent stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $936,976 | August 1, 2022 | June 30, 2024 | LIN, CHIEN-CHI | reporter.nih.gov |
| Microphysiology Systems Database Supplement to Tissue Chips for Precision Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia-Supplement | NIH | National Center for Advancing Translational Sciences | 2021 | $932,065 | August 1, 2020 | June 30, 2022 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Notch-enriched Mesenchymal Stromal Cells for Bone Allograft Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $932,010 | January 1, 2019 | December 31, 2025 | DONG, YUFENG | reporter.nih.gov |
| Explore the APOE e4-mediated p53 activation in Alzheimer's Disease | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $928,125 | February 1, 2019 | January 31, 2024 | ZHAO, RUI | reporter.nih.gov |
| Optimization of electromechanical monitoring of engineered heart tissues | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $924,063 | April 1, 2023 | March 31, 2025 | MCNALLY, ELIZABETH M | reporter.nih.gov |
| Establishing and benchmarking advanced methods to comprehensively characterize somatic genome variation in single human cells | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $922,052 | April 19, 2023 | March 31, 2025 | URBAN, ALEXANDER ECKEHART | reporter.nih.gov |
| The Role of MDM2 in FMRP regulation of neuronal development | NIH | National Institute of Mental Health | 2021 to 2022 | $917,272 | July 9, 2018 | April 30, 2024 | ZHAO, XINYU | reporter.nih.gov |
| Exploring the Pathophysiology of AD and ADRDs with 3D Asteroid Models | NIH | National Institute on Aging | 2021 | $916,247 | September 15, 2021 | August 31, 2024 | WOLOZIN, BENJAMIN L | reporter.nih.gov |
| Effect of Microgravity on Drug Responses Using Engineered Heart Tissues | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $911,144 | July 22, 2022 | January 31, 2023 | WU, JOSEPH C. | reporter.nih.gov |
| Cell and Molecular Consequences of Alzheimer's Disease Genetic Variants on BBB Integrity and Function | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $908,817 | September 15, 2020 | August 31, 2025 | YOUNG-PEARSE, TRACY L | reporter.nih.gov |
| High throughput platform for simultaneous multiparametric assessment of cardiac physiology for heart failure drug development | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $908,049 | September 1, 2023 | June 30, 2026 | MERCOLA, MARK | reporter.nih.gov |
| Development and validation of a novel bioprinted, human-diabetic cardiac organoid model | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $906,000 | September 15, 2020 | August 31, 2025 | HAN, KYUNG-AN | reporter.nih.gov |
| Development of Pharmacological Treatment of Osteochondromas | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $905,493 | February 1, 2019 | January 31, 2025 | ENOMOTO-IWAMOTO, MOTOMI | reporter.nih.gov |
| 2/2 - Cell Type and Region-Specific Regulatory Networks in Human Brain Development and Disorders | NIH | National Institute of Mental Health | 2021 to 2022 | $903,832 | August 15, 2018 | May 31, 2023 | STATE, MATTHEW W. | reporter.nih.gov |
| The Cdk5/35 Kinase | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $903,600 | April 1, 1996 | June 30, 2023 | TSAI, LI-HUEI | reporter.nih.gov |
| Do we need Y chromosome for successful reproduction? | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $886,145 | August 25, 2012 | March 31, 2024 | WARD, MONIKA A | reporter.nih.gov |
| Development and Maintenance of the Human Photoreceptor-Bipolar Cell Synapse. | NIH | National Eye Institute | 2021 to 2024 | $884,824 | June 1, 2020 | May 31, 2025 | NAGIEL, AARON | reporter.nih.gov |
| Nonsense-Mediated mRNA Decay and Nonsense-Mediated mRNA Decay Factors | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $884,498 | August 1, 1999 | July 31, 2023 | MAQUAT, LYNNE E | reporter.nih.gov |
| Connecting TDP-43 Pathology to the Molecular Profiles of Neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $879,816 | August 15, 2020 | July 31, 2025 | GALE HAMMELL, MOLLY | reporter.nih.gov |
| Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems | NIH | National Center for Advancing Translational Sciences | 2021 | $875,910 | July 15, 2020 | July 31, 2022 | HIMMELFARB, JONATHAN | reporter.nih.gov |
| AI-guided miniproteins driving the production and functional endurance of pancreatic islet tissue from pluripotent stem cells. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $875,714 | September 1, 2024 | August 31, 2025 | CIRULLI, VINCENZINO | reporter.nih.gov |
| lncRNAs and Anesthetic-Induced Developmental Neurotoxicity | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $871,546 | May 15, 2014 | May 31, 2024 | BAI, XIAOWEN | reporter.nih.gov |
| Regulation of diverse microglial phenotypes in neurodegeneration | NIH | National Institute on Aging | 2023 | $871,419 | September 15, 2023 | August 31, 2025 | JAYADEV, SUMAN | reporter.nih.gov |
| REGULATION OF NICHE CELL DIFFERENTIATION TO SUSTAIN INTESTINAL STEM CELL REGENERATION AGAINST GUT INFLAMMATION | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $870,194 | January 1, 2020 | December 31, 2024 | HAN, XIAONAN | reporter.nih.gov |
| Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $869,959 | August 18, 2023 | July 31, 2025 | CLELLAND, CLAIRE | reporter.nih.gov |
| Targeting the Mutant H3.3 Pathway in Glioma | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $868,352 | September 30, 2018 | June 30, 2024 | KNOEPFLER, PAUL S | reporter.nih.gov |
| Engineering human islet-like organoids for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $865,040 | September 30, 2018 | May 31, 2022 | EVANS, RONALD M | reporter.nih.gov |
| Integration of systems and synthetic biology to advance development of human tissues ex vivo | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $852,965 | September 30, 2019 | June 30, 2024 | EBRAHIMKHANI, MO REZA | reporter.nih.gov |
| Determining the role of OXR1 in aging and Alzheimer's disease | NIH | National Institute on Aging | 2021 | $851,414 | September 30, 2021 | August 31, 2023 | KAPAHI, PANKAJ | reporter.nih.gov |
| Molecular Basis of Human Hepatic Progenitor Cell Formation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $846,782 | July 1, 2014 | June 30, 2024 | DUNCAN, STEPHEN A | reporter.nih.gov |
| Gene Therapy for Hearing and Balance Disorders | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $846,072 | August 1, 2018 | July 31, 2023 | COREY, DAVID P | reporter.nih.gov |
| Regulation of UBE3A Imprinted Expression | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $833,150 | September 1, 2018 | August 31, 2025 | GRAVELEY, BRENTON R. | reporter.nih.gov |
| Functional characterization of Alzheimer's disease associated genetic variants | NIH | National Institute on Aging | 2021 | $831,005 | September 30, 2017 | May 31, 2023 | SHEN, YIN | reporter.nih.gov |
| microRNA therapies for advanced brain tumors | NIH | National Cancer Institute | 2022 to 2024 | $828,287 | April 1, 2020 | December 31, 2025 | BHERE, DEEPAK | reporter.nih.gov |
| Myocardial Repair with a Novel Engineered Cardiac Muscle Patch | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $825,686 | September 1, 2019 | August 31, 2025 | ZHU, WUQIANG | reporter.nih.gov |
| Mechanisms and Treatment of Cardiac and Skeletal Muscular Dysfunction in Barth Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $823,560 | February 6, 2021 | April 30, 2024 | PACAK, CHRISTINA A. | reporter.nih.gov |
| Genomic Prediction of Doxorubicin-Induced Cardiotoxicity | NIH | National Cancer Institute | 2021 to 2022 | $822,880 | September 13, 2018 | August 31, 2023 | BURRIDGE, PAUL W. | reporter.nih.gov |
| iPSC-Derived Airway Basal Cells to Model Human Airway Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $822,064 | September 1, 2018 | August 31, 2024 | HAWKINS, FINN | reporter.nih.gov |
| Diversity Supplement -- Vertebrate Photoreceptor Development and Regeneration | NIH | National Eye Institute | 2021 to 2022 | $817,376 | August 1, 2012 | July 31, 2024 | MORRIS, ANN C | reporter.nih.gov |
| Molecular Diagnostics using a Nanopore to Analyze Secretions from Single Cells | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $809,222 | March 1, 2019 | February 28, 2025 | TIMP, GREGORY LOUIS | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Rutgers University New Brunswick | New Brunswick, NJ | 8 | $48.4 million | 0 | $0 |
| Stanford University | Stanford, CA | 58 | $48.1 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 35 | $46.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 35 | $35.2 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 40 | $34.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 45 | $32.3 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 31 | $31.4 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 32 | $29.3 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 25 | $28.7 million | 0 | $0 |
| Emory University | Atlanta, GA | 28 | $28.5 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 11 | $27.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 22 | $27 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 12 | $24.4 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 37 | $24.4 million | 0 | $0 |
| University of Washington | Seattle, WA | 31 | $24 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 8 | $22.8 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 4 | $22.7 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 28 | $21.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 28 | $21.6 million | 0 | $0 |
| Washington University | Saint Louis, MO | 29 | $21 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 21 | $20.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 27 | $20.3 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 16 | $20.3 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 11 | $18.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 16 | $17.5 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 15 | $15.6 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 14 | $15 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 23 | $14.8 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 14 | $14.4 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 27 | $14.1 million | 0 | $0 |
| Yale University | New Haven, CT | 11 | $13.8 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 8 | $13.3 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 7 | $13.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 12 | $12.8 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 15 | $12.4 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 11 | $10.8 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 7 | $10.8 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 3 | $10.6 million | 0 | $0 |
| University of Rochester | Rochester, NY | 10 | $10.6 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 12 | $10.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 7 | $9.6 million | 0 | $0 |
| Harvard University | Cambridge, MA | 10 | $9.3 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 10 | $9 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 9 | $8.7 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 5 | $8.7 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 8 | $8.3 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 10 | $8.2 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 3 | $7.8 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 3 | $7.7 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 8 | $7.6 million | 0 | $0 |
| Buck Institute for Research on Aging | Novato, CA | 5 | $7.3 million | 0 | $0 |
| The Emmes Company, LLC | Rockville, MD | 1 | $7.3 million | 0 | $0 |
| Regenerative Research Foundation | Albany, NY | 4 | $7 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 8 | $7 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 12 | $7 million | 0 | $0 |
| University of Chicago | Chicago, IL | 11 | $7 million | 0 | $0 |
| Versiti Blood Health, Inc. | Milwaukee, WI | 3 | $6.7 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 12 | $6.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 8 | $6.6 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 9 | $6.5 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 5 | $6.5 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 1 | $6.4 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 5 | $6.4 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 5 | $5.9 million | 0 | $0 |
| Quiver Bioscience Inc. | Cambridge, MA | 3 | $5.8 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 9 | $5.7 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 6 | $5.6 million | 0 | $0 |
| Upstate Medical University | Syracuse, NY | 5 | $5.5 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 5 | $5.1 million | 0 | $0 |
| Georgetown University | Washington, DC | 3 | $5.1 million | 0 | $0 |
| Vala Sciences, Inc. | San Diego, CA | 4 | $5.1 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 7 | $5 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 3 | $4.9 million | 0 | $0 |
| Duke University | Durham, NC | 7 | $4.7 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 6 | $4.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 4 | $4.6 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 5 | $4.5 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 2 | $4.4 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 11 | $4.2 million | 0 | $0 |
| University of California at Davis | Davis, CA | 8 | $4.2 million | 0 | $0 |
| Altis Biosystems, Inc. | Durham, NC | 3 | $4.1 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 4 | $4 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 4 | $3.9 million | 0 | $0 |
| Endeavor Health Clinical Operations | Evanston, IL | 2 | $3.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 4 | $3.5 million | 0 | $0 |
| Stem Pharm, Inc. | Madison, WI | 4 | $3.4 million | 0 | $0 |
| University of California-Santa Cruz | Santa Cruz, CA | 2 | $3.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 5 | $3.3 million | 0 | $0 |
| Rockefeller University | New York, NY | 3 | $3.2 million | 0 | $0 |
| Adventhealth Orlando | Orlando, FL | 2 | $3.2 million | 0 | $0 |
| Lieber Institute, Inc. | Baltimore, MD | 3 | $3.1 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 3 | $3.1 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 5 | $3 million | 0 | $0 |
| New York Medical College | Valhalla, NY | 3 | $3 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 3 | $3 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 7 | $3 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 8 | $2.9 million | 0 | $0 |
| Modulo Bio, Inc. | San Diego, CA | 1 | $2.9 million | 0 | $0 |
| Massachusetts Eye and Ear Infirmary | Boston, MA | 1 | $2.9 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 2 | $2.9 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 5 | $16,425,378 | 0 | $0 |
| 2024 | 442 | $204,238,872 | 0 | $0 |
| 2023 | 682 | $316,562,000 | 0 | $0 |
| 2022 | 837 | $395,972,025 | 0 | $0 |
| 2021 | 920 | $460,114,010 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.